In this episode of Fellows Forum, @yaelmaxwell.bsky.social talks with Grant Reed, Angelo Oliva, and Raunak M. Nair on how they broach difficult conversations with patients and educate other practitioners to do them effectively and empathically. #TCT2025 www.tctmd.com/videos/hard-...

TCTMD celebrates its 25th anniversary! Listen to the editorial team reflect on the website's greatest hits over the years. www.tctmd.com/audio/tctmd-... @yaelmaxwell.bsky.social @lamckeown1.bsky.social

"I felt crazy as a senior cardiac surgeon making TikTok videos," said Dan Engelman at #EACTS2025. "But it turns out that’s what people watch. . . . And they want the message in one minute, it turns out, or less." #CardioSky www.tctmd.com/news/educati...

"Given the known bleeding risk with oral anticoagulants, the very low AF burden questions current ESC guidelines recommending long-term oral anticoagulation," said Florian Herrmann. #EACTS2025 #CardioSky www.tctmd.com/news/nearly-...

My first story from #EACTS2025 dives into a unique analysis comparing 5-year TAVI vs SAVR mortality that provoked some strong feelings about what type of research should inform guidelines. #CardioSky www.tctmd.com/news/savr-be...

Looking forward to being at #EACTS2025. Full coverage to come on @tctmd.bsky.social

“The time-sensitive nature of transthyretin cardiomyopathy is something that has been on many people’s minds, but I think this is the first piece of evidence that should push us forward,” said Ahmad Masri, MD at #HFSA2025. #CardioSky

In the phase III CELEBRATE trial, the novel injectable glycoprotein IIb/IIIa inhibitor zalunfiban has met its primary safety and efficacy outcomes in STEMI patients. Read more here: www.tctmd.com/news/celebra...

“You often learn from when science goes the opposite direction from what you expect,” said presenter David Berg, MD. The next question to answer is what role GDF-15 plays in heart failure. #HFSA2025 #CardioSky

Another from #HFSA2025: this time looking at a new CCM-D device in patients with HFrEF. Will this be enough for CCM to gain traction in the HF world? #CardioSky

My first from #HFSA2025 and an interesting one to boot! The Cordio HearO App can pick up signals of heart failure events more than 3 weeks before they happen. #CardioSky

The first plenary session at #HFSA2025 is about to begin and all of my coverage will be on ⁦‪@tctmd.bsky.social!‬⁩ Who else is here and what are you looking forward to at the meeting?

What's new in the world of cardiology? In this month's Heart Sounds, the TCTMD team highlights their favorite stories from September, and @DrRobRoswell joins to discuss DAPT-SHOCK-AMI. Full episode here: www.tctmd.com/audio/top-ca... @yaelmaxwell.bsky.social

Earlier, less invasive treatment is the name of the game according to new @escardio.bsky.social and @eacts.bsky.social valvular heart disease guidelines. #ESCongress www.tctmd.com/news/esceact...

On the latest On Record, @yaelmaxwell.bsky.social, Gilbert Tang, and Tsuyoshi Kaneko discuss reinterventions after TAVI during #NYValves2025. Watch the full video here: www.tctmd.com/videos/on-re...

New US hypertension guidelines, the first since 2017, released today reinforce prior recs that prioritize lowering BP early and aggressively, with special emphasis on lifestyle, the connection between BP and cognitive function, and pregnancy. #CardioSky www.tctmd.com/news/new-acc...

During #NYValves2025, Patrick O'Gara, Michael Borger, and @yaelmaxwell.bsky.social discussed how the FDA approval of asymptomatic TAVI has changed practice, with perspectives from the US and Europe. Watch the full episode of On Record here: www.tctmd.com/videos/on-re...

In this episode of Heart Sounds, our TCTMD journalists discuss the top news in cardiology for July. @lamckeown1.bsky.social @yaelmaxwell.bsky.social @toddneale.bsky.social www.tctmd.com/audio/top-ca...

I set up a Signal account if anyone would prefer to reach me there.

Whether a patient undergoes CAC screening depends on the type of doctor they see, with large sex differences observed over the past decade at a single healthcare system, according to retrospective data. #SCCT2025 #CardioSky www.tctmd.com/news/cardiol...

Intensive medical therapy usual care for reducing noncalcified coronary plaque in women who have INOCA, according to results of a serial imaging subanalysis of the WARRIOR trial. #SCCT2025 #CardioSky @damini-d.bsky.social www.tctmd.com/news/less-pl...

New in the @tctmd.bsky.social Fellows in Focus Feed: Attendees at #Fellows2025 tell us how they define success in medicine. #FellowsForum #CardioSKy www.tctmd.com/videos/defin... @abdullahalabcha.bsky.social

Leaders in the field of cardiac CT celebrated 20 years of science, innovation, and overcoming challenges during a special session at the 2025 @scct-heart.bsky.social meeting. #SCCT2025 #CardioSky www.tctmd.com/news/leaders...

AI-QCT can potentially improve preventive care for patients, especially women, thought to be at risk for ASCVD, according to an analysis of the CERTAIN study. #SCCT2025 #CardioSky www.tctmd.com/news/ai-qct-...

For symptomatic patients who’ve undergone CCTA, added knowledge gleaned from AI-CPA (@heartflow.bsky.social) changes the management strategy more than half the time, according to new data from the DECIDE registry. tctmd.com/news/ai-base... @cianpmccarthy.bsky.social #SCCT2025 #Cardiosky

Among more than 300 young, fit firefighters, CCTA led to 3.6% undergoing a diagnostic cath and 28.6% being referred to a cardiologist for medical or lifestyle management. Among the 2/3 with 0 CAC, 83% had noncalcified plaque. #SCCT2025 #CardioSky www.tctmd.com/news/adding-...

I’m excited to be in Montréal for #scct2025. Who else is here and what are you most looking forward to hearing about? (And where can I find the best poutine in town?😉)

"It’s not so much that one therapy is better than another, but there are consequences to everything that we do," says Isaac George. www.tctmd.com/news/carbon-... #cardiosky

"It’s not so much that one therapy is better than another, but there are consequences to everything that we do," says Isaac George. www.tctmd.com/news/carbon-... #CardioSky

TEER with the Pascal system in patients with degenerative MR results in good early survival outcomes, significant reductions in MR, and improvements in quality of life, according to an analysis of the STS/ACC TVT Registry. #NYValves2025 #CardioSky www.tctmd.com/news/good-ou...

My 1st from #NYValves2025 (and my 1st time at this meeting!): Surgical explant is associated with better long-term survival compared with redo TAVI in a population of Medicare patients requiring reintervention. @ShinFukuharaMD @DrBowdish @TsuyoshiKaneko1 www.tctmd.com/news/long-te...

What's more valuable in cardiology: iterative innovation or totally disruptive new technologies? I spoke with Azeem Latib and Jose Calle Gordo about this topic and more for @tctmd.bsky.social's #OnRecord. #CardioSky www.tctmd.com/videos/on-re...

Anyone else have trouble keeping all the post-PCI DAPT data straight? I spoke with Dominick Angiolillo at #EuroPCR for our #OnRecord series to summarize where we are now and what questions remain. #CardioSky www.tctmd.com/videos/on-re...

Cardiac mortality rates have increased in Massachusetts annually since the start of the COVID-19 pandemic in 2020, with exaggerated seasonal patterns and upticks in at-home deaths, according to new population-based data. #CardioSky www.tctmd.com/news/rising-...

At #EuroPCR, I sat down with @eurointervention.bsky.social EIC @dfcapodanno.bsky.social for @tctmd.bsky.social's #OnRecord to chat about what it means to leave a legacy in cardiovascular medicine. www.tctmd.com/videos/on-re...

Coronary function testing done during the index angiography in patients with ANOCA is not only feasible and safe but also can improve disease-related quality of life over time compared with standard care, according to data from ILIAS ANOCA #EuroPCR #CardioSky www.tctmd.com/news/early-c...

IVL has become a standard lesion preparation method in calcified lesions in our cats lab and we use it almost daily. Reassuring that new data proves it safe. IMO we need to have some convincing clinical outcome data for this expensive device as well but this may require a huge trial. #cardiosky.

Intravascular lithotripsy can safely aid in lesion preparation before PCI in patients with severe calcification and can lower the rate of postprocedural patient adverse outcomes, according to data from 2 new studies presented #EuroPCR. #CardioSky www.tctmd.com/news/ivl-eff...

Cardiac damage is present in 4 out of every 5 patients with asymptomatic AS and is tied to worse prognosis over time, but new EARLY TAVR data suggest that TAVI improves clinical outcomes regardless of the extent of that damage #EuroPCR #CardioSky www.tctmd.com/news/early-t...

As day 2 of #EuroPCR begins, make sure to check out all of the @tctmd.bsky.social team coverage. #CardioSky @lamckeown1.bsky.social @michaeltctmd.bsky.social www.tctmd.com/conference/e...

Immediate multivessel PCI offers similar survival out to 180 days when compared with culprit-only PCI among STEMI patients with cardiogenic shock, according to provocative new data from the DanGer Shock trial. #EuroPCR #CardioSky www.tctmd.com/news/immedia...

20 years ago, research predicted 29.5% of women would have hypertension by 2025. By 2019, it was already 32%. ❌ Still underdiagnosed ❌ Still undertreated ❌ Still overlooked It's time for change. #WorldHypertensionDay 🔗www.thelancet.com/jo... 🔗academic.oup.com/eur...

Attention fellows, come find me during the next break outside the session room to participate in a video interview for @TCTMD’s #FellowsForum. #Fellows2025

While spontaneous MIs are associated with worse quality of life both early and late, procedural MIs don’t appear to have a lasting impact on disease-specific QoL, according to new data from the invasive-management arm of the ISCHEMIA trial. #CardioSky www.tctmd.com/news/procedu...

4D flow CMR can more accurately estimate peak aortic valve velocities than traditional TTE in patients with aortic stenosis, according to data from the PREFER-CMR registry. #cardiosky www.tctmd.com/news/four-di...

Although the genes that affect Lp(a) in European and East Asian populations might vary, the downstream clinical effects that stem from high Lp(a) levels are similar, according to data from the UK and China. #CardioSky www.tctmd.com/news/lpa-gen...

Lorundrostat, a novel aldosterone synthase inhibitor, can substantially lower BP in patients with uncontrolled and treatment-resistant hypertension, according to new findings from the phase IIb Advance-HTN trial. #CardioSky www.tctmd.com/news/lorundr...

1-year follow-up data suggest that a novel TTVR device may provide another potential alternative to surgery for patients with severe tricuspid regurgitation. #CardioSky www.tctmd.com/news/lux-val...

“We talk about lifetime management, but if the first valve lasts longer, that is better than any reintervention,” said Tsuyoshi Kaneko. #CardioSky

What's Next for the ABCVM? Yael L. Maxwell (@yaelmaxwell.bsky.social), Jeffrey Kuvin, Edward Fry, and Janice Sibley share their thoughts on where the ABCVM is headed following the recent rejection from the ABMS. Watch the full video: www.tctmd.com/videos/whats...